In contrast, our analysis of pre-treatment tumor tissue samples shows that melanoma patients whose tumors were evaluated as PD-L1 positive by both the physicians and the digital algorithm had a BOR on ICB of 60.4%, indicating that tissue PD-L1 expression has predictive value. The gene discussed is CD274; the disease is melanoma.